IC
GILD icon

Institutional Capital’s Gilead Sciences GILD Stock Holding History

Institutional Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$25.7M Buy
358,506
+37,767
+12% +$2.81M 0.38% 42
2016
Q3 		$25.4M Buy
+320,739
New +$26.1M 0.35% 45

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Institutional Capital's GILD Position: Q4 2016 in Review

Institutional Capital increased its Gilead Sciences (GILD) stake by 12% in Q4 2016, buying an estimated $2.81M and bringing the position to 358,506 shares worth $25.7M. The position accounts for 0.38% of the portfolio, ranked #42.

Institutional Capital first reported a position in GILD in Q3 2016 and has held it in 2 quarters since. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Institutional Capital held 358,506 shares of Gilead Sciences worth $25.7M as of Q4 2016.
  • Institutional Capital bought 37,767 Gilead Sciences shares in Q4 2016, an estimated $2.81M.
  • Gilead Sciences made up 0.38% of Institutional Capital's portfolio in Q4 2016, its #42 holding.
  • Institutional Capital first reported a position in Gilead Sciences in Q3 2016 and has held it in 2 quarters since.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Institutional Capital's 13F filing for Q4 2016, filed 2 Feb 2017.